Cancer stage and consideration of cannabis use among adult cancer survivors in Southern California
Open Access
- 7 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Monographs
- Vol. 2024 (66) , 282-289
Abstract
Background: The benefits of cannabis in symptom management among cancer survivors are widely acknowledged; however, patterns of cannabis use by cancer stage at diagnosis are unknown. Methods: Here, we examined the association between cancer stage at diagnosis and consideration of cannabis use since diagnosis. We analyzed cross-sectional survey data from 954 cancer survivors, weighted to be representative of a National Cancer Institute–Designated Comprehensive Cancer Center’s patient population. We used survey-weighted multivariable logistic regression to examine the association between cancer stage at diagnosis (advanced [III/IV] versus non-advanced [I/II]) and consideration of cannabis use (yes versus no) since diagnosis. Results: Sixty percent of the population was diagnosed with non-advanced stages of cancer, and 42% had considered using cannabis since diagnosis. The odds of consideration of cannabis use were 63% higher (odds ratio = 1.63, 95% confidence interval = 1.06 to 2.49) among cancer survivors diagnosed at stages III/IV than among those diagnosed at stages I/II. Conclusion: Cancer stage may be a predictor of consideration of cannabis use after diagnosis.Keywords
Funding Information
- NCI (P30 CA023100-34S3)
- San Diego State University
- University of California San Diego Cancer Partnership (U54 CA132384, U54 CA132379)
- Moores Cancer Center
- UC San Diego Health (P30 CA023100)
- NCI (K01 CA234317)
- University of California San Diego Cancer Center Partnership (U54 CA132384, U54 CA132379)
- San Diego Alzheimer’s Disease Resource Center for Minority Aging Research (P30 AG059299)
This publication has 28 references indexed in Scilit:
- Cannabis use among adults undergoing cancer treatmentCancer, 2023
- Cannabis use among cancer survivors in 22 states: Results from the Behavioral Risk Factor Surveillance System, 2020Cancer, 2023
- Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sampleCancer, 2021
- Prevalence of cannabis use among individuals with a history of cancer in the United StatesCancer, 2021
- Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factorsSupportive Care in Cancer, 2018
- Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational useCancer, 2017
- Cannabis in cancer careClinical Pharmacology & Therapeutics, 2015
- The P harmacologic and C linical E ffects of M edical C annabisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Symptom burden in cancer survivors 1 year after diagnosisCancer, 2011
- Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.Supportive Care in Cancer, 2008